AwardTape · Defense awards · Cygnos Biotech, LLC
Cygnos Biotech, LLC: $1.6M in DoD and DHS awards
Cygnos Biotech, LLC holds 2 DoD and DHS prime awards with $1.6M obligated Mar 4, 2025 to May 15, 2026. Largest category: Defense systems R&D at $1.4M; largest buyer: Department of the Army at $1.6M.
| Obligated FY2024+ | $1.6M |
|---|---|
| Awards | 2 |
| FY2024 | $0 |
| FY2025 | $204K |
| FY2026 to date | $1.4M |
| Lifetime obligated on these awards | $1.6M |
| First and latest action | Mar 4, 2025 · May 15, 2026 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Defense systems R&D | $1.4M | 1 awards | 87% |
| 2 | Health R&D | $204K | 1 awards | 13% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Department of the Army | $1.6M | 2 awards | 100% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| W911SR26CA003 definitive contract | $1.4M | The purpose of this small business innovation research (sbir) phase ii contract is to show efficacy of anti-viral treatment with the pvx therapeutic. | Army | Defense systems R&D | May 15, 2026 DoD 90d |
| W911SR25C0013 definitive contract | $204K | Research to create a class of agnostic drugs targeting the host to assist in fighting off a broad spectrum of viral pathogens. | Army | Health R&D | Mar 4, 2025 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial